363 related articles for article (PubMed ID: 29706626)
21. Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization.
Ye Y; Xu Y; Lai Y; He W; Li Y; Wang R; Luo X; Chen R; Chen T
J Cell Biochem; 2018 Mar; 119(3):2951-2963. PubMed ID: 29131381
[TBL] [Abstract][Full Text] [Related]
22. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells.
Yuan CH; Sun XM; Zhu CL; Liu SP; Wu L; Chen H; Feng MH; Wu K; Wang FB
Oncotarget; 2015 Oct; 6(31):32138-53. PubMed ID: 26451607
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.
Pan QZ; Pan K; Zhao JJ; Chen JG; Li JJ; Lv L; Wang DD; Zheng HX; Jiang SS; Zhang XF; Xia JC
Cancer Immunol Immunother; 2013 Nov; 62(11):1675-85. PubMed ID: 24061617
[TBL] [Abstract][Full Text] [Related]
24. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
[TBL] [Abstract][Full Text] [Related]
26. CD8
Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
[TBL] [Abstract][Full Text] [Related]
27. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
[TBL] [Abstract][Full Text] [Related]
28. TIM-3 as a marker of exhaustion in CD8
Mohammadizad H; Shahbazi M; Hasanjani Roushan MR; Soltanzadeh-Yamchi M; Mohammadnia-Afrouzi M
Microb Pathog; 2019 Mar; 128():323-328. PubMed ID: 30660734
[TBL] [Abstract][Full Text] [Related]
29. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
[TBL] [Abstract][Full Text] [Related]
30. CD8
Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
[TBL] [Abstract][Full Text] [Related]
31. Tim-3 expression and its role in hepatocellular carcinoma.
Liu F; Liu Y; Chen Z
J Hematol Oncol; 2018 Oct; 11(1):126. PubMed ID: 30309387
[TBL] [Abstract][Full Text] [Related]
32. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.
Zheng C; Zheng L; Yoo JK; Guo H; Zhang Y; Guo X; Kang B; Hu R; Huang JY; Zhang Q; Liu Z; Dong M; Hu X; Ouyang W; Peng J; Zhang Z
Cell; 2017 Jun; 169(7):1342-1356.e16. PubMed ID: 28622514
[TBL] [Abstract][Full Text] [Related]
33. Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.
Lee KA; Shin KS; Kim GY; Song YC; Bae EA; Kim IK; Koh CH; Kang CY
Aging Cell; 2016 Apr; 15(2):291-300. PubMed ID: 26750587
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of CD8
Pu Q; Yu L; Liu X; Yan H; Xie Y; Cai X; Wu Y; Du J; Yang Z
Front Immunol; 2024; 15():1375864. PubMed ID: 38650927
[TBL] [Abstract][Full Text] [Related]
35. TIM3
Chen K; Gu Y; Cao Y; Fang H; Lv K; Liu X; He X; Wang J; Lin C; Liu H; Zhang H; He H; Xu J; Li H; Li R
Br J Cancer; 2022 Jan; 126(1):100-108. PubMed ID: 34725458
[TBL] [Abstract][Full Text] [Related]
36. Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.
Li B; Wang Y; Chen J; Wu H; Chen W
Clin Exp Immunol; 2005 May; 140(2):310-9. PubMed ID: 15807856
[TBL] [Abstract][Full Text] [Related]
37. Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.
Rallón N; García M; García-Samaniego J; Cabello A; Álvarez B; Restrepo C; Nistal S; Górgolas M; Benito JM
PLoS One; 2018; 13(3):e0193829. PubMed ID: 29518102
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
[TBL] [Abstract][Full Text] [Related]
39. DNA of Neutrophil Extracellular Traps Binds TMCO6 to Impair CD8+ T-cell Immunity in Hepatocellular Carcinoma.
Song M; Zhang C; Cheng S; Ouyang D; Ping Y; Yang J; Zhang Y; Tang Y; Chen H; Wang QJ; Li YQ; He J; Xiang T; Zhang Y; Xia JC
Cancer Res; 2024 May; 84(10):1613-1629. PubMed ID: 38381538
[TBL] [Abstract][Full Text] [Related]
40. Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors.
Ngiow SF; von Scheidt B; Akiba H; Yagita H; Teng MW; Smyth MJ
Cancer Res; 2011 May; 71(10):3540-51. PubMed ID: 21430066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
